Butterfly Network to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Butterfly Network (NYSE: BFLY), a digital health company specializing in handheld whole-body ultrasound technology, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The conference will take place from January 13-16, 2025, at the Westin St. Francis in San Francisco.
President, CEO & Chairman Joseph DeVivo and EVP & CFO Heather Getz will present on January 16, 2025, at 7:30 AM PST. The presentation will be available via webcast on the Events & Presentations section of Butterfly's investor website and will remain accessible for replay until February 15, 2025.
Butterfly Network (NYSE: BFLY), una società di salute digitale specializzata nella tecnologia di ultrasuoni a corpo intero portatile, ha annunciato la sua partecipazione al 43° Annuale J.P. Morgan Healthcare Conference. La conferenza si svolgerà dal 13 al 16 gennaio 2025, presso il Westin St. Francis di San Francisco.
Il Presidente, CEO e Chairman Joseph DeVivo e il EVP e CFO Heather Getz presenteranno il 16 gennaio 2025, alle 7:30 AM PST. La presentazione sarà disponibile tramite webcast nella sezione Eventi e Presentazioni del sito web dedicato agli investitori di Butterfly e rimarrà accessibile per la riascolto fino al 15 febbraio 2025.
Butterfly Network (NYSE: BFLY), una empresa de salud digital especializada en tecnología de ultrasonido de cuerpo completo portátil, ha anunciado su participación en la 43.ª Conferencia Anual de Salud de J.P. Morgan. La conferencia se llevará a cabo del 13 al 16 de enero de 2025, en el Westin St. Francis en San Francisco.
El Presidente, CEO y Chairman Joseph DeVivo y la EVP y CFO Heather Getz presentarán el 16 de enero de 2025, a las 7:30 AM PST. La presentación estará disponible a través de un webcast en la sección de Eventos y Presentaciones del sitio web para inversores de Butterfly y permanecerá accesible para su repetición hasta el 15 de febrero de 2025.
버터플라이 네트워크 (NYSE: BFLY), 휴대용 전신 초음파 기술을 전문으로 하는 디지털 헬스 회사가 제43회 JP모건 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 이 컨퍼런스는 2025년 1월 13일부터 16일까지 샌프란시스코의 웨스틴 세인트 프랜시스에서 열릴 예정입니다.
회장, CEO이자 의장인 조셉 드비보와 EVP이자 CFO인 헤더 겟츠가 2025년 1월 16일 오전 7시 30분 PST에 발표할 예정입니다. 이 발표는 버터플라이 투자자 웹사이트의 이벤트 및 프레젠테이션 섹션을 통해 웹캐스트로 제공되며, 2025년 2월 15일까지 재생 가능하게 접근할 수 있습니다.
Butterfly Network (NYSE: BFLY), une entreprise de santé numérique spécialisée dans la technologie d'échographie corporelle portable, a annoncé sa participation à la 43e conférence annuelle J.P. Morgan Healthcare. La conférence se déroulera du 13 au 16 janvier 2025 au Westin St. Francis à San Francisco.
Le Président, CEO et Président du Conseil Joseph DeVivo et la EVP et CFO Heather Getz présenteront le 16 janvier 2025 à 7h30 PST. La présentation sera disponible en webdiffusion dans la section Événements et Présentations du site web des investisseurs de Butterfly et restera accessible en replay jusqu'au 15 février 2025.
Butterfly Network (NYSE: BFLY), ein digitales Gesundheitsunternehmen, das sich auf tragbare Ultraschalltechnologie für den ganzen Körper spezialisiert hat, hat seine Teilnahme an der 43. J.P. Morgan Healthcare-Konferenz angekündigt. Die Konferenz findet vom 13. bis 16. Januar 2025 im Westin St. Francis in San Francisco statt.
Präsident, CEO und Vorsitzender Joseph DeVivo sowie EVP und CFO Heather Getz werden am 16. Januar 2025 um 7:30 Uhr PST präsentieren. Die Präsentation wird über einen Webcast im Bereich Veranstaltungen und Präsentationen der Investorenseite von Butterfly verfügbar sein und bis zum 15. Februar 2025 für ein Nachspielen zugänglich bleiben.
- None.
- None.
A webcast of the presentation will be posted on the Events & Presentations section of the Butterfly investor website, and available for replay until February 15, 2025.
To schedule a meeting with Mr. DeVivo and Ms. Getz, please reach out to the Company directly via the contacts below or request a one-on-one through your J.P. Morgan representative.
About Butterfly Network
Founded by Dr. Jonathan Rothberg in 2011, Butterfly Network is a digital health company with a mission to democratize medical imaging by making high-quality ultrasound affordable, easy-to-use, globally accessible, and intelligently connected, including for the 4.7 billion people around the world lacking access to ultrasound. Butterfly created the world's first handheld single-probe, whole-body ultrasound system using semiconductor technology, Butterfly iQ. The company has continued to innovate, leveraging the benefits of Moore’s Law, to launch its second generation Butterfly iQ+ in 2020, and third generation iQ3 in 2024 – each with increased processing power and performance enhancements. The disruptive technology has been recognized by TIME’s Best Inventions, Fast Company’s World Changing Ideas, CNBC Disruptor 50, and MedTech Breakthrough Awards, among other accolades. With its proprietary Ultrasound-on-Chip™ technology, intelligent software, and educational offerings, Butterfly is paving the way to mass adoption of ultrasound for earlier detection and remote management of health conditions around the world. Butterfly devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of
View source version on businesswire.com: https://www.businesswire.com/news/home/20241216695937/en/
Butterfly Investors:
Heather Getz
Chief Financial and Operations Officers, Butterfly Network
investors@butterflynetwork.com
and
Steve Halper, LifeSci Advisors (IR Representative)
646-876-6455
shalper@lifesciadvisors.com
Source: Butterfly Network
FAQ
When is Butterfly Network (BFLY) presenting at the 2025 J.P. Morgan Healthcare Conference?
How long will the BFLY J.P. Morgan Healthcare Conference presentation webcast be available?
Who will be presenting for Butterfly Network (BFLY) at the J.P. Morgan Healthcare Conference?
Where can investors access Butterfly Network's (BFLY) J.P. Morgan Healthcare Conference presentation?
